SN40R2 and WM35-R cell lines with resistance to MDM2/p53 binding antagonists were generated by continuously exposing SJSA-1 osteosarcoma cells [20] and WM35 cutaneous melanoma cells to either Nutlin-3 or RG7388 respectively. This evidence concerns the gene MDM2 and osteosarcoma.